Vaccine News and Research

Latest Vaccine News and Research

Study reveals rising oropharyngeal cancer incidence and mortality trends in all 50 states

Oropharyngeal cancer incidence among men is continuing to rise rapidly in nearly all 50 states and among women living in states in the Midwest and Southeast regions, according to a new study by investigators at The University of Texas Health Science Center at Houston School of Public Health in JAMA Otolaryngology-Head & Neck Surgery.

16 Dec 2021

25 million people in the UK have had COVID-19 top up jab

More than 25 million people in the UK have had a COVID-19 top up jab, as the vaccination programme is turbocharged to get all eligible adults boosted as soon as possible.

16 Dec 2021

G7 health ministers issue statement on the global threat of Omicron variant

G7 health ministers today held their final meeting of the UK's G7 Presidency, focusing particularly on the very worrying developments on Omicron.

16 Dec 2021

NIH scientists highlight the urgent need for universal coronavirus vaccines

A growing body of scientific evidence, considered together with ecological reality, strongly suggest that novel coronaviruses will continue to infect bats and other animal reservoirs and potentially emerge to pose a pandemic threat to humans.

16 Dec 2021

KHN’s ‘What the Health?’: Oh, oh, omicron

This week, the U.S. passed the milestone of 800,000 dead from covid-19, as hospitals are starting to fill following the Thanksgiving holiday and the ominous omicron variant starts to spread rapidly.

16 Dec 2021

New study demonstrates SARS-CoV-2 Omicron antibody escape

A new study examined the neutralization of virus variants using three sets of antibodies: serum from individuals vaccinated or infected with earlier variants of the virus; concentrated human antibodies from plasma donors; and approved monoclonal antibodies.

16 Dec 2021

Moderna booster vaccination overcomes SARS-CoV-2 Omicron variant antibody escape

A new study reports the results of a study focused on immune evasion characteristics, specifically the ability to escape neutralization by antibodies to the earlier SARS-CoV-2 variants or to the spike antigen used in COVID-19 vaccines.

16 Dec 2021

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, today announced the launch of A5355, a clinical trial studying a new cytomegalovirus (CMV) vaccine in adults with both HIV and CMV.

16 Dec 2021

Using fungal vaccine to train stem cells and enhance immune response to infections

The research group Immunology of Fungal Infections at the University of Valencia (UV) has investigated a fungal vaccine with which to train stem cells and hematopoietic progenitors (which produce all the cells of the blood and lifelong immune system) to improve the immune response to infections. The work has been published in the journal Frontiers in Immunology.

16 Dec 2021

Therapeutic antibodies deemed ineffective against Omicron variant of SARS-CoV-2

A new study found that the Omicron S protein evades antibodies with a 44-fold higher efficiency than the Delta variant's spike, rendering therapeutic antibodies ineffective and likely negatively impacting antibody protection induced by infection or double vaccination.

16 Dec 2021

Capability of BNT162b2 vaccine given in 2 or 3 doses to neutralize SARS-CoV-2 Omicron

The team observed that three doses of the BNT162b2 (Pfizer-BioNTech) mRNA vaccine are required to mount an effective antibody response against the Omicron variant.

16 Dec 2021

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

A new study has used this assay to evaluate sera, obtained from 239 individuals vaccinated via any of the above-stated vaccines against SARS-CoV-2’s original strain, the Delta, and Omicron SARS-CoV-2 pseudoviruses.

16 Dec 2021

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Scientists identified a human monoclonal antibody (mAb), which successfully neutralized or bound all sarbecoviruses tested in vitro.

16 Dec 2021

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

A new study determines the ability of individuals with varying exposure to SARS-CoV-2 infection and vaccination, to neutralize SARS- CoV-2 pseudotypes.

16 Dec 2021

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Researchers from Westmead Hospital have been investigating the effect of a third dose on neutralizing antibody titres in already vaccinated individuals.

16 Dec 2021

Covid shots for kids are scarce — and demand is mixed — in rural Montana

When children ages 5 to 11 were approved for Pfizer's lower-dose pediatric covid-19 vaccine in November, Annie Edwards was eager to get her daughter Hannah, then 5, the shot because of underlying health conditions she has stemming from her premature birth.

16 Dec 2021

Vaccine effectiveness of mRNA-1273 during the emergence of the SARS-CoV-2 Delta variant

The authors highlight that their research confirms the effectiveness of two doses of mRNA-1273 against SARS-CoV-2 infection.

16 Dec 2021

Study: Older people are less likely to fall for Covid-19 scams than younger or middle-aged adults

As the Covid-19 pandemic was unfolding, a surge in scams targeting people’s fears was seen across the globe.

16 Dec 2021

Research provides reassuring data on the risk of heart inflammation after SARS-CoV-2 vaccination

A study published by The BMJ today provides more reassuring data on the risk of heart inflammation (myocarditis or myopericarditis) after mRNA vaccination against the covid-19 virus.

16 Dec 2021

Two doses of Moderna COVID-19 vaccine highly effective against all SARS-CoV-2 variants

Kaiser Permanente research published on December 15, 2021 in The British Medical Journal showed 2 doses of Moderna COVID-19 vaccine were highly effective against all SARS-CoV-2 variants; however, vaccine effectiveness against the delta variant moderately declined with increasing time after vaccination.

15 Dec 2021

Vaccine News and Research

Latest Vaccine News and Research

Study reveals rising oropharyngeal cancer incidence and mortality trends in all 50 states

25 million people in the UK have had COVID-19 top up jab

G7 health ministers issue statement on the global threat of Omicron variant

NIH scientists highlight the urgent need for universal coronavirus vaccines

KHN’s ‘What the Health?’: Oh, oh, omicron

New study demonstrates SARS-CoV-2 Omicron antibody escape

Moderna booster vaccination overcomes SARS-CoV-2 Omicron variant antibody escape

ACTG announces the launch of clinical trial to evaluate new CMV vaccine in adults

Using fungal vaccine to train stem cells and enhance immune response to infections

Therapeutic antibodies deemed ineffective against Omicron variant of SARS-CoV-2

Capability of BNT162b2 vaccine given in 2 or 3 doses to neutralize SARS-CoV-2 Omicron

Neutralization potency of COVID-19 vaccine boosters against SARS-CoV-2 variant pseudoviruses

Human monoclonal antibody protects against SARS-CoV-2 and SARS-CoV in vivo

Exploring the plasma neutralization properties of the Omicron variant of SARS-CoV-2

Study suggests Omicron can be neutralized by BNT162b2 recipient sera optimally after three vaccine doses

Covid shots for kids are scarce — and demand is mixed — in rural Montana

Vaccine effectiveness of mRNA-1273 during the emergence of the SARS-CoV-2 Delta variant

Study: Older people are less likely to fall for Covid-19 scams than younger or middle-aged adults

Research provides reassuring data on the risk of heart inflammation after SARS-CoV-2 vaccination

Two doses of Moderna COVID-19 vaccine highly effective against all SARS-CoV-2 variants

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in